Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 14, 2014Clinical CardiologyOpen Access

Prevention of Cardiovascular Disease: Highlights for the Clinician of the 2013 American College of Cardiology/American Heart Association Guidelines

View Full Paper
Ask AI
Bookmark
Share

Population

Patients at risk for atherosclerotic cardiovascular disease (ASCVD)

Comparison

2013 ACC/AHA guideline recommendations vs Prior conventional strategies

Design

Review

Authors

NWNanette K. Wenger

Discussion

Loading...

Member takes

Overview

May guide statin allocation to four risk groups without LDL targets; leaves open optimal BP goals in older adults.

Key Points

  • To summarize the major updates and clinical recommendations established by the 2013 ACC/AHA guidelines for the prevention of atherosclerotic cardiovascular disease.
  • Synthesized updated ACC/AHA recommendations covering cardiovascular risk assessment, lifestyle intervention, obesity management, and cholesterol control.
  • Evaluated the application of the Pooled Cohort Equations and risk-based thresholds for initiating statin therapy.
  • Identified four distinct patient groups with the greatest statin benefit: established ASCVD, LDL-C ≥ 190 mg/dL, diabetes aged 40–75 with LDL-C 70–189 mg/dL, and a 10-year ASCVD risk ≥ 7.5%.
  • Replaced arbitrary LDL-C numerical targets with risk-guided statin intensity and mandatory patient-physician risk-benefit discussions.
  • Highlighted lifestyle modification for lipid and blood pressure control, while noting unresolved consensus on blood pressure goals in older adults.

Structured PICO

P
Population
Patients at risk for atherosclerotic cardiovascular disease (ASCVD)
I
Intervention
2013 ACC/AHA guideline recommendations (lifestyle management, statin therapy based on risk groups, blood pressure control)
C
Comparator
Prior conventional strategies (e.g., arbitrary LDL-C treatment targets)
O
Outcome
Reduction of atherosclerotic cardiovascular risk (mortality and major nonfatal events)

The 2013 ACC/AHA guidelines represent a paradigm shift in cardiovascular prevention by eliminating LDL-C targets and focusing on risk-based statin allocation using the Pooled Cohort Equations.

Cite This Study

Nanette K. Wenger (2014) studied this question.

synapsesocial.com/papers/6a71193ce36a167817e2ed7chttps://doi.org/10.1002/clc.22264
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New Guidelines to Reduce Risk of Atherosclerotic Cardiovascular Disease2014 · 13 citations
  2. 2Beyond LDL-C: Modern Lipid Management for ASCVD Prevention in Primary Care2026
  3. 3The New ACC/AHA Cardiovascular Risk Guidelines: Impact and Controversies2014 · 2 citations
  4. 4The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components2016 · 2 citations
  5. 52019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines2019 · 4,538 citations